MEDIUM confidence: 100% data completeness, but the composite (58) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-08-23.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $194 (last qtr, 9 analysts) → $200 (last mo, 4) (+3.0%).
Buy-rated share 25% → 19% over ~3 months (-6pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $3.76 | $4.37 | +16.2% |
| May 2026 | $2.99 | $3.32 | +11.0% |
| Feb 2026 | $3.50 | $3.94 | +12.6% |
| Nov 2025 | $2.43 | $2.76 | +13.6% |
| Aug 2025 | $3.30 | $3.53 | +7.0% |
| May 2025 | $2.72 | $2.98 | +9.6% |
| Feb 2025 | $3.26 | $5.45 | +67.2% |
| Nov 2024 | $2.37 | $2.50 | +5.5% |
Net insider -$1.4M over 180 days (0 open-market buys, 5 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4.7B— | $5.5B+15.7% | $5.9B+7.9% | $6.3B+6.1% | $6.5B+3.7% |
| EPS (dil.) | $9.21— | $9.96+8.1% | $11.08+11.2% | $16.00+44.4% | $9.65-39.7% |
| Free Cash Flow | $1.3B— | $993M-20.7% | $1.1B+6.0% | $1.4B+31.4% | $1.2B-15.0% |
| Gross Margin | 69.5% | 69.1%-0.4pp | 67.8%-1.3pp | 67.7%-0.1pp | 67.7%-0.1pp |
| Operating Margin | 19.3% | 20.1%+0.7pp | 20.9%+0.8pp | 18.4%-2.5pp | 15.8%-2.7pp |
| Net Margin | 16.8% | 14.8%-2.0pp | 14.9%+0.2pp | 20.0%+5.1pp | 11.2%-8.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 4.3%/yr (revenue basis).
Base free cash flow $1.2B (avg FY2023–FY2025; latest year $1.2B) · equity value $14.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 58 indicates a moderately attractive stock, with the short-term score of 61 being notably higher than the long-term score of 55. Gartner's QScore is driven up by its strong momentum, with a 51% return over the past three months, and high profitability, as evidenced by its ROE near 400% and operating margin of 17.3%. However, the stock's value and growth scores are lower, due in part to a P/E of 20.5 and negative EPS growth of 40%.